Profile data is unavailable for this security.
About the company
Lionco Pharmaceutical Group Co.,Ltd. is a China-based company principally engaged in the research and development, production and sales of chemical prescription medicine. The Company's products are mainly categorized in to three areas: parenteral nutrition agents, anti-infectious agents and digestive system agents. The lead product of its parenteral nutrition agents is Glutamine for injection; its anti-infectious agents include Cefodizime sodium for injection and Cefathiamidine for injection, among others; its digestive system agents include Omeprazole Sodium for injection and others. The Company operates its business in domestic market.
- Revenue in CNY (TTM)200.39m
- Net income in CNY-144.55m
- Incorporated2003
- Employees475.00
- LocationLionco Pharmaceutical Group Co LtdMedicine Valley Industrial ParkNo. 16 Medicine Valley Erheng RoadNational Hi-tech Industrial Dvlpmnt ZneSHANNAN 856000ChinaCHN
- Phone+86 8 937830999
- Fax+86 8 937830888
- Websitehttp://www.lingkang.com.cn/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Obio Technology Shanghai Corp Ltd | 233.59m | -138.37m | 2.87bn | 731.00 | -- | 1.42 | -- | 12.28 | -0.2157 | -0.2157 | 0.3624 | 3.11 | 0.0921 | 3.37 | 2.52 | 319,545.50 | -5.45 | 0.2246 | -5.99 | 0.2514 | -9.53 | 36.72 | -59.21 | 1.48 | 2.39 | -- | 0.1103 | 0.00 | -29.69 | 35.88 | -425.90 | -- | 57.00 | -- |
Shanghai MicuRx Pharmaceutical Co Ltd | 106.52m | -467.10m | 3.01bn | 205.00 | -- | 4.06 | -- | 28.30 | -0.7129 | -0.7129 | 0.1626 | 1.13 | 0.0839 | 0.5802 | 5.74 | 519,588.20 | -36.81 | -- | -40.09 | -- | 81.75 | -- | -438.53 | -- | 6.94 | -- | 0.2497 | -- | 88.31 | -- | -91.16 | -- | -- | -- |
Lionco Pharmaceutical Group Co Ltd | 200.39m | -144.55m | 3.22bn | 475.00 | -- | 3.50 | -- | 16.05 | -0.2071 | -0.2071 | 0.2826 | 1.27 | 0.1182 | 1.86 | 2.52 | 421,872.40 | -8.52 | 0.7396 | -9.94 | 0.9562 | 42.74 | 80.88 | -72.13 | 2.08 | 6.19 | -5.98 | 0.3512 | 521.93 | -31.95 | -34.79 | 22.65 | -- | -33.18 | -- |
Shanghai OPM Biosciences Co Ltd | 254.91m | 49.43m | 3.28bn | 285.00 | 66.44 | 1.52 | -- | 12.87 | 0.4303 | 0.4303 | 2.22 | 18.80 | 0.1095 | 2.07 | 2.54 | 894,431.90 | 2.09 | 4.34 | 2.16 | 4.65 | 58.86 | 58.31 | 19.06 | 23.40 | 19.91 | -- | 0.0315 | 45.38 | -17.41 | 48.34 | -48.72 | -- | 6.09 | -- |
Tibet Weixinkang Medicine Co Ltd | 1.29bn | 248.69m | 3.45bn | 701.00 | 13.88 | 2.40 | -- | 2.67 | 0.5715 | 0.5715 | 2.96 | 3.30 | 0.7114 | 18.19 | 5.88 | 1,840,383.00 | 13.71 | 8.20 | 17.78 | 11.13 | 50.81 | 50.20 | 19.28 | 11.53 | 3.10 | -- | 0.0045 | 59.11 | -5.43 | 12.13 | 20.94 | 23.85 | -5.61 | 38.96 |
Data as of Jul 23 2024. Currency figures normalised to Lionco Pharmaceutical Group Co Ltd's reporting currency: Chinese Yuan Renminbi CNY
0.97%Per cent of shares held by top holders
Holder | Shares | % Held |
---|---|---|
China Asset Management Co., Ltd.as of 31 Dec 2023 | 3.72m | 0.52% |
Gfund Management Co., Ltd.as of 31 Dec 2023 | 1.98m | 0.28% |
SWS MU Fund Management Co., Ltd.as of 31 Dec 2023 | 1.26m | 0.18% |
Zhong Ou Asset Management Co., Ltdas of 31 Dec 2023 | 0.00 | 0.00% |
More ▼
Data from 31 Dec 2023 - 27 Jun 2024Source: FactSet Research Systems Inc.